BE2021C506I2 - - Google Patents

Download PDF

Info

Publication number
BE2021C506I2
BE2021C506I2 BE2021C506C BE2021C506C BE2021C506I2 BE 2021C506 I2 BE2021C506 I2 BE 2021C506I2 BE 2021C506 C BE2021C506 C BE 2021C506C BE 2021C506 C BE2021C506 C BE 2021C506C BE 2021C506 I2 BE2021C506 I2 BE 2021C506I2
Authority
BE
Belgium
Prior art keywords
antigens
streptococcus
prophylaxis
therapy
useful
Prior art date
Application number
BE2021C506C
Other languages
French (fr)
Original Assignee
Id Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Id Biomedical Corp filed Critical Id Biomedical Corp
Publication of BE2021C506I2 publication Critical patent/BE2021C506I2/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/315—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Streptococcus (G), e.g. Enterococci
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)

Abstract

The present invention relates to antigens more particularly antigens of Streptococcus pyogenes (also called group A Streptococcus (GAS)) bacterial pathogen which are useful as vaccine component for therapy and/or prophylaxis.
BE2021C506C 2000-12-21 2021-02-09 BE2021C506I2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25694000P 2000-12-21 2000-12-21
PCT/CA2001/001853 WO2002050107A2 (en) 2000-12-21 2001-12-21 Streptococcus pyogenes antigens and corresponding dna fragments

Publications (1)

Publication Number Publication Date
BE2021C506I2 true BE2021C506I2 (en) 2021-05-31

Family

ID=22974225

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2021C506C BE2021C506I2 (en) 2000-12-21 2021-02-09

Country Status (12)

Country Link
US (5) US7595057B2 (en)
EP (1) EP1343895B1 (en)
JP (1) JP4080876B2 (en)
AT (1) ATE398677T1 (en)
AU (2) AU1686302A (en)
BE (1) BE2021C506I2 (en)
BR (1) BR0116704A (en)
CA (2) CA2432525C (en)
DE (1) DE60134494D1 (en)
ES (1) ES2307564T3 (en)
FR (1) FR21C1005I2 (en)
WO (1) WO2002050107A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
GB0130228D0 (en) * 2001-12-18 2002-02-06 Hansa Medica Ab Protein
CA2535863A1 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
GB201502306D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) 2015-02-12 2015-04-01 Hansa Medical Ab Protein

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5854416A (en) * 1991-11-14 1998-12-29 The United States Of America As Represented By The Department Of Health And Human Services Streptococcus pneumoniae 37-KDA surface adhesin a protein and nucleic acids coding therefor
US6287574B1 (en) 1995-03-17 2001-09-11 Biochem Pharma Inc. Proteinase K resistant surface protein of neisseria meningitidis
ID27482A (en) * 1998-02-20 2001-04-12 Iaf Biochem Int GROUP STREPTOCOCCUS ANTIGENES B
GB9807890D0 (en) 1998-04-09 1998-06-10 Actinova Ltd Peptides
JP2002531054A (en) 1998-07-27 2002-09-24 マイクロビアル テクニクス リミティッド Nucleic acids and proteins from group B streptococci
DE69935986D1 (en) 1998-07-27 2007-06-14 Sanofi Pasteur Ltd STREPTOCOCCUS PNEUMONIAE PROTEINS AND NUCLEIC ACIDS
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9828880D0 (en) 1998-12-31 1999-02-17 Actinova Ltd Protein
US7074415B2 (en) * 2000-06-20 2006-07-11 Id Biomedical Corporation Streptococcus antigens
EP1297145B1 (en) * 2000-07-06 2008-10-29 ID Biomedical Corporation Streptococcus pyogenes antigen
CA2424433A1 (en) * 2000-10-13 2002-04-18 Shire Biochem Inc. Bvh-a2 and bvh-a3 antigens of group b streptococcus
EP2189473A3 (en) * 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
AU1686302A (en) * 2000-12-21 2002-07-01 Shire Biochem Inc Streptococcus pyogenes antigens and corresponding dna fragments
CA2438921C (en) * 2001-02-21 2012-04-10 Shire Biochem Inc. Streptococcus pyogenes polypeptides and corresponding dna fragments
BR0208874A (en) * 2001-04-13 2004-06-22 Wyeth Corp Surface proteins of streptococcus pyogenes
CA2453062C (en) * 2001-07-06 2013-04-02 Shire Biochem Inc. Group b streptococcus bvh-a5 antigens and corresponding dna fragments
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
EP1456231A2 (en) * 2001-12-20 2004-09-15 Shire Biochem Inc. Streptococcus antigens
AU2003246495A1 (en) * 2002-07-15 2004-02-02 Id Biomedical Corporation Polypeptide of streptococcus pyogenes
CA2535863A1 (en) * 2003-08-15 2005-02-24 Id Biomedical Corporation Polypeptides of streptococcus pyogenes
AU2005294275B2 (en) * 2004-10-08 2012-09-13 Glaxosmithkline Biologicals S.A. Immunogenic and therapeutic compositions for Streptococcus pyogenes
WO2006131347A2 (en) * 2005-06-09 2006-12-14 Hansa Medical Ab Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection
US8309096B2 (en) * 2007-01-15 2012-11-13 Glaxosmithkline Biologicals S.A. Fusion protein
WO2009033670A2 (en) * 2007-09-14 2009-03-19 Genovis Ab Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection
GB201003920D0 (en) * 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Method of treatment
GB201115841D0 (en) * 2011-09-13 2011-10-26 Genovis Ab Protein and method
GB201316744D0 (en) * 2013-09-20 2013-11-06 Genovis Ab Method
GB201416849D0 (en) * 2014-09-24 2014-11-05 Genovis Ab Method

Also Published As

Publication number Publication date
US20100119507A1 (en) 2010-05-13
US20150017684A1 (en) 2015-01-15
ATE398677T1 (en) 2008-07-15
US20040097706A1 (en) 2004-05-20
US9340586B2 (en) 2016-05-17
WO2002050107A2 (en) 2002-06-27
ES2307564T3 (en) 2008-12-01
DE60134494D1 (en) 2008-07-31
US8298551B2 (en) 2012-10-30
CA2432525C (en) 2012-11-27
AU2002216863B8 (en) 2008-03-20
ES2307564T9 (en) 2021-04-26
US7595057B2 (en) 2009-09-29
US20130136760A1 (en) 2013-05-30
AU2002216863B2 (en) 2008-02-28
AU1686302A (en) 2002-07-01
JP4080876B2 (en) 2008-04-23
FR21C1005I2 (en) 2022-01-14
US8821895B2 (en) 2014-09-02
CA2432525A1 (en) 2002-06-27
FR21C1005I1 (en) 2021-03-26
US20160326221A1 (en) 2016-11-10
EP1343895A2 (en) 2003-09-17
CA2789252A1 (en) 2002-06-27
CA2789252C (en) 2016-11-15
BR0116704A (en) 2003-12-23
WO2002050107A3 (en) 2003-04-10
EP1343895B1 (en) 2008-06-18
JP2004524014A (en) 2004-08-12

Similar Documents

Publication Publication Date Title
BE2021C506I2 (en)
AU7227001A (en) Streptococcus pyogenes antigens
AU2001278003A1 (en) Bacteriophage having multiple host range
WO2006042027A8 (en) Immunogenic and therapeutic compositions for streptococcus pyogenes
MY125202A (en) Vaccine
HUP0100623A2 (en) Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugates vaccines
WO2004030608A3 (en) Nanoemulsion vaccines
ZA200109995B (en) Nematicidal Trifluorobutenes.
MY129319A (en) Crystal forms of azithromycin
AU2002319229A1 (en) Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
PL374080A1 (en) Processes for the preparation of fibrinogen
GB0216002D0 (en) Process and composition
WO2002066650A3 (en) Streptococcus pyogenes polypeptides and corresponding dna fragments
IL156799A0 (en) Peptides having affinity for the gp120 viral protein and use thereof
WO2002028889A3 (en) Haemophilus influenzae antigens and corresponding dna fragments
AU2002327795A1 (en) Methods and compositions for production and purification of recombinant staphylococcal enterotoxin b (rseb)
NZ295877A (en) A vaccine comprising the helicobacter bacterium and its use
DE60234772D1 (en) GROUP-B STREPTOCOCCUS ANTIGENIC AND CORRESPONDING DNA FRAGMENTS
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies
WO2003059252A3 (en) Use of a novel cell surface protease from group b streptococcus
UA49450A (en) Recombinant inactivated vaccine against infectious rhinotracheitis of cattle
GB9919732D0 (en) Trehalose producing cells as vaccines
UA67250A (en) Strain bovinae herpesvirus-1 "moldavian" for the preparation of vaccines and diagnosticums
TW200519206A (en) Methods for producing novel medaka and novel medaka